Global Value, Access and Commercialization Director – Regenerative Medicines
Core
Lead global market access, pricing, and reimbursement strategies for regenerative medicine assets outside the US, ensuring alignment with central global strategy and operationalizing value frameworks.
Role type
Senior Director, Global Market Access & Commercialization (Regenerative Medicine)
Builds
Global launch readiness, HTA submissions, and pricing/reimbursement pathways for cell & gene therapies and biologics in OUS markets.
Domain
Global Healthcare / Regenerative Medicine / Cell & Gene Therapy
Deliverable
production ML models | product features | dashboards & analysis | research | client delivery | infrastructure | physical/clinical work
Required skills
Global market access strategy, pricing and reimbursement planning, HTA negotiation, cross-functional leadership, strategic planning, stakeholder management, risk identification, long-range planning, evidence synthesis
Preferred skills
Experience in cell/gene/regenerative medicines, EU market knowledge, JCA experience, rare disease therapeutics, specialty biologics, tissue-based therapies, external partner management
Technologies
None stated
Responsibilities
Lead development and execution of OUS market access, pricing, and reimbursement strategies; Translate global strategic objectives into actionable OUS launch plans; Drive OUS launch readiness activities for access pathways and pricing; Identify market-specific access risks and reimbursement barriers; Lead HTA planning and execution across priority markets including EU JCA; Develop country-level pricing and reimbursement recommendations; Represent ex-US access perspectives in cross-functional planning forums
Seniority
Director, strategic leadership with hands-on execution